Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population

Journal of Medical Virology

Volumn 82, Issue 9, 2010, Pages 1501-1507

  Ma, Juan ^a   Guo, Xinhui ^b   Wu, Xiaopan ^a   Li, Junhong ^b   Zhu, Xilin ^a   Li, Zhuo ^b   Li, Jingyun ^a   Pan, Liping ^a   Li, Tianjie ^a   Li, Hui ^a   Liu, Ying ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Hepatitis B virus; NK cell lectin like receptors; NKG2d receptor

Indexed keywords

CD94 ANTIGEN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL RECEPTOR NKG2F; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMORPHISM, SINGLE NUCLEOTIDE;

HEPATITIS B VIRUS;

EID: 77956576431     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21855     Document Type: Article

References (31)

1. Aktas E, Erten G, Kucuksezer UC, Deniz G. 2009. Natural killer cells: Versatile roles in autoimmune and infectious diseases. Expert Rev Clin Immunol 5:405-420.
2. Arase H, Lanier LL. 2004. Specific recognition of virus-infected cells by paired NK receptors. Rev Med Virol 14:83-93. (Pubitemid 38316008)
3. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729. (Pubitemid 129505074)
4. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. 1999. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 17:189-220.
5. Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thelu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E. 2009. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 51:458-467.
6. Boonstra A, Woltman AM, Janssen HL. 2008. Immunology of hepatitis B and hepatitis C virus infections. Best Pract Res Cl Ga 22:1049-1061.
7. Burgess SJ, Maasho K, Masilamani M, Narayanan S, Borrego F, Coligan JE. 2008. The NKG2D receptor: Immunobiology and clinical implications. Immunol Res 40:18-34. (Pubitemid 351378033)
8. Chemin I, Zoulim F. 2009. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 286:52-59.
9. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z. 2005. Activation and function of hepatic NK cells in hepatitis B infection: An under-investigated innate immune response. J Viral Hepatitis 12:38-45. (Pubitemid 40188772)
10. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH. 2006. Association between chronic hepatitis B virus infection and interieukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroen Hepatol 21:1163-1169. (Pubitemid 43910009)
11. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, Das A, Lopes AR, Borrow P, Williams K, Humphreys E, Afford S, Adams DH, Bertoletti A, Maini MK. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204:667-680.
12. Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J. 2006. Regulation of NKG2D ligand gene expression. Hum Immunol 67:159-169. (Pubitemid 43673921)
13. Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58:974-982.
14. Gunturi A, Berg RE, Forman J. 2004. The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res 30:29-34. (Pubitemid 38998648)
15. Hayashi T, Imai K, Morishita Y, Hayashi I, Kusunoki Y, Nakachi K. 2006. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res 66:563-570. (Pubitemid 43166065)
16. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. 2004. The role of the NKG2D immunoreceptor in immune cell activation and natural killing (vol. 17, p. 19, 2002). Immunity 20:799-799.
17. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192:921-930.
18. Kim DK, Kabat J, Borrego F, Sanni TB, You CH, Coligan JE. 2004. Human NKG2F is expressed and can associate with DAP12. Mol Immunol 41:53-62. (Pubitemid 38609396)
19. Lanier LL. 2005. NK cell recognition. Annu Rev Immunol 23:225-274.
20. Liaw YF, Chu CM. 2009. Hepatitis B virus infection. Lancet 373:582-592.
21. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, Kwang TY, Hsu ST, Lin SY, Hsu LC. 1989. Hepatitis-B virus markers in chinese twins. Anticancer Res 9:737-741.
22. Maddrey WC. 2000. Hepatitis B: An important public health issue. J Med Virol 61:362-366. (Pubitemid 30368539)
23. McMahon BJ. 2009. The Natural History of Chronic Hepatitis B Virus Infection. Hepatology 49:S45-S55.
24. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197-223. (Pubitemid 32368034)
25. Obeidy P, Sharland AF. 2009. NKG2D and its ligands. Int J Biochem Cell B 41:2364-2367.
26. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S, Mondelli MU. 2009. Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections. Gastroenterology 137:1151-1160.
27. Ramezani A, Roshan MRH, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA. 2008. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroen Hepatol 23:1716-1721.
28. Romphruk AV, Romphruk A, Naruse TK, Raroengjai S, Puapairoj C, Inoko H, Leelayuwat C. 2009. Polymorphisms of NKG2D ligands: Diverse RAET1/ULBP genes in Northeastern Thais. Immunogenetics 61:611-617.
29. Szabo G, Mandrekar P, Dolganiuc A. 2007. Innate immune response and hepatic inflammation. Semin Liver Dis 27:339-350. (Pubitemid 350071835)
30. Zhou J, Chen DQ, Poon VKM, Zeng Y, Ng F, Lu LW, Huang JD, Yuen KY, Zheng BJ. 2009a. A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection. Immunogenetics 61:423-430.
31. Zhou J, Smith DK, Lu L, Poon VKM, Ng F, Chen DQ, Huang JD, Yuen KY, Cao KY, Zheng BJ. 2009b. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J Viral Hepatitis 16:45-52.